BACKGROUND: We have recently demonstrated in man that a functional allelic polymorphism in the Haptoglobin (Hp) gene plays a major role in determining survival and congestive heart failure after myocardial infarction (MI). We sought to recapitulate the effect of Hp type on outcomes and cardiac remodeling after MI in transgenic mice. METHODS: The Hp 2 allele exists only in man. Wild type C57Bl/6 mice carry the Hp 1 allele with high homology to the human Hp 1 allele. We genetically engineered a murine Hp 2 allele and targeted its insertion by homologous recombination to the murine Hp locus to create Hp 2 mice. Diabetes Mellitus (DM) was induced with streptozotocin. MI was produced by occlusion of the left anterior descending artery in DM C57Bl/6 mice carrying the Hp 1 or Hp 2 allele. MI size was determined with TTC staining. Left ventricular (LV) function and dimensions were assessed by 2-dimensional echocardiography. RESULTS: In the absence of DM, Hp 1-1 and Hp 2-2 mice had similar LV dimensions and LV function. MI size was similar in DM Hp 1-1 and 2-2 mice 24 hours after MI (50.2 +/- 2.1%and 46.9 +/- 5.5%, respectively, p = 0.6). However, DM Hp 1-1 mice had a significantly lower mortality rate than DM Hp 2-2 mice 30 days after MI (HR 0.41, 95% CI (0.19-0.95), p = 0.037 by log rank). LV chamber dimensions were significantly increased in DM Hp 2-2 mice compared to DM Hp 1-1 mice 30 days after MI (0.196 +/- 0.01 cm2 vs. 0.163 +/- 0.01 cm2, respectively; p = 0.029). CONCLUSION: In DM mice the Hp 2-2 genotype is associated with increased mortality and more severe cardiac remodeling 30 days after MI.
BACKGROUND: We have recently demonstrated in man that a functional allelic polymorphism in the Haptoglobin (Hp) gene plays a major role in determining survival and congestive heart failure after myocardial infarction (MI). We sought to recapitulate the effect of Hp type on outcomes and cardiac remodeling after MI in transgenic mice. METHODS: The Hp 2 allele exists only in man. Wild type C57Bl/6 mice carry the Hp 1 allele with high homology to the humanHp 1 allele. We genetically engineered a murine Hp 2 allele and targeted its insertion by homologous recombination to the murine Hp locus to create Hp 2 mice. Diabetes Mellitus (DM) was induced with streptozotocin. MI was produced by occlusion of the left anterior descending artery in DM C57Bl/6 mice carrying the Hp 1 or Hp 2 allele. MI size was determined with TTC staining. Left ventricular (LV) function and dimensions were assessed by 2-dimensional echocardiography. RESULTS: In the absence of DM, Hp 1-1 and Hp 2-2 mice had similar LV dimensions and LV function. MI size was similar in DMHp 1-1 and 2-2 mice 24 hours after MI (50.2 +/- 2.1%and 46.9 +/- 5.5%, respectively, p = 0.6). However, DMHp 1-1mice had a significantly lower mortality rate than DM Hp 2-2 mice 30 days after MI (HR 0.41, 95% CI (0.19-0.95), p = 0.037 by log rank). LV chamber dimensions were significantly increased in DM Hp 2-2 mice compared to DMHp 1-1mice 30 days after MI (0.196 +/- 0.01 cm2 vs. 0.163 +/- 0.01 cm2, respectively; p = 0.029). CONCLUSION: In DMmice the Hp 2-2 genotype is associated with increased mortality and more severe cardiac remodeling 30 days after MI.
Authors: Shany Blum; Roy Asaf; Julia Guetta; Rachel Miller-Lotan; Rabea Asleh; Ran Kremer; Nina S Levy; Franklin G Berger; Doron Aronson; Xiaoming Fu; Renliang Zhang; Stanley L Hazen; Andrew P Levy Journal: J Am Coll Cardiol Date: 2006-12-13 Impact factor: 24.094
Authors: Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard Journal: J Am Coll Cardiol Date: 2002-12-04 Impact factor: 24.094
Authors: Dominique P V de Kleijn; Mirjam B Smeets; Patrick P C W Kemmeren; Sai K Lim; Ben J Van Middelaar; Evelyn Velema; Arjan Schoneveld; Gerard Pasterkamp; Cornelius Borst Journal: FASEB J Date: 2002-05-21 Impact factor: 5.191
Authors: Nicole L Lohr; David C Warltier; William M Chilian; Dorothee Weihrauch Journal: Am J Physiol Heart Circ Physiol Date: 2004-11-18 Impact factor: 4.733
Authors: Melissa Simpson; Janet K Snell-Bergeon; Gregory L Kinney; Orit Lache; Rachel Miller-Lotan; Yefim Anbinder; Marian J Rewers; Andrew P Levy Journal: Cardiovasc Diabetol Date: 2011-11-20 Impact factor: 9.951